HK1144073A1 - Water-immiscible materials as vehicles for drug delivery - Google Patents
Water-immiscible materials as vehicles for drug deliveryInfo
- Publication number
- HK1144073A1 HK1144073A1 HK10110618.9A HK10110618A HK1144073A1 HK 1144073 A1 HK1144073 A1 HK 1144073A1 HK 10110618 A HK10110618 A HK 10110618A HK 1144073 A1 HK1144073 A1 HK 1144073A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vehicles
- water
- drug delivery
- immiscible materials
- immiscible
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title 1
- 239000000463 material Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98530807P | 2007-11-05 | 2007-11-05 | |
PCT/US2008/080665 WO2009061607A2 (en) | 2007-11-05 | 2008-10-22 | Water-immiscible materials as vehicles for drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1144073A1 true HK1144073A1 (en) | 2011-01-28 |
Family
ID=40185076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10110618.9A HK1144073A1 (en) | 2007-11-05 | 2010-11-15 | Water-immiscible materials as vehicles for drug delivery |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100286121A1 (zh) |
EP (1) | EP2214644B1 (zh) |
JP (1) | JP2011502990A (zh) |
KR (1) | KR20100067684A (zh) |
CN (1) | CN101848701A (zh) |
AU (1) | AU2008325036B2 (zh) |
BR (1) | BRPI0819175A2 (zh) |
CA (1) | CA2703000C (zh) |
ES (1) | ES2402321T3 (zh) |
HK (1) | HK1144073A1 (zh) |
MX (1) | MX2010004366A (zh) |
SG (1) | SG185955A1 (zh) |
WO (1) | WO2009061607A2 (zh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8399006B2 (en) | 2009-01-29 | 2013-03-19 | Forsight Vision4, Inc. | Posterior segment drug delivery |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
US10166142B2 (en) | 2010-01-29 | 2019-01-01 | Forsight Vision4, Inc. | Small molecule delivery with implantable therapeutic device |
PL2600930T3 (pl) | 2010-08-05 | 2021-09-06 | Forsight Vision4, Inc. | Urządzenie wstrzykujące do dostarczania leku |
US9492315B2 (en) | 2010-08-05 | 2016-11-15 | Forsight Vision4, Inc. | Implantable therapeutic device |
CN103153316B (zh) | 2010-08-05 | 2015-08-19 | 弗赛特影像4股份有限公司 | 组合药物递送方法和设备 |
EP2640360A2 (en) | 2010-11-19 | 2013-09-25 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US10398592B2 (en) | 2011-06-28 | 2019-09-03 | Forsight Vision4, Inc. | Diagnostic methods and apparatus |
ES2864203T3 (es) | 2011-09-16 | 2021-10-13 | Forsight Vision4 Inc | Aparato de intercambio de fluido |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US9827191B2 (en) * | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
KR102310775B1 (ko) | 2012-05-03 | 2021-10-07 | 칼라 파마슈티컬스, 인크. | 개선된 점막 수송을 나타내는 제약 나노입자 |
CA2871745C (en) | 2012-05-03 | 2023-01-24 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
WO2014152959A1 (en) | 2013-03-14 | 2014-09-25 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
EP2978393B1 (en) | 2013-03-28 | 2023-12-27 | ForSight Vision4, Inc. | Ophthalmic implant for delivering therapeutic substances |
US11344531B2 (en) * | 2014-03-27 | 2022-05-31 | Servicio Andaluz De Salud | Durable preparation of an injectable of melatonin exhibiting long-term stability |
RU2695563C2 (ru) | 2014-07-15 | 2019-07-24 | Форсайт Вижн4, Инк. | Способ и устройство для доставки глазного имплантата |
RU2017105844A (ru) | 2014-08-08 | 2018-09-11 | Форсайт Вижн4, Инк. | Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения |
JP7037360B2 (ja) | 2014-11-10 | 2022-03-16 | フォーサイト・ビジョン フォー・インコーポレーテッド | 拡張可能な薬物送達デバイス |
US11324800B2 (en) | 2015-01-15 | 2022-05-10 | Wellspring Ophthalmics, Inc. | Aqueous suspensions of cyclosporin |
US20200237859A1 (en) | 2019-01-25 | 2020-07-30 | Newport Research, Inc. | Aqueous suspensions of cyclosporin |
JP2018510872A (ja) * | 2015-03-23 | 2018-04-19 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 高濃度かつ/または高粘度の活性薬剤溶液を注射するための方法および組成物 |
EP3377009B1 (en) | 2015-11-20 | 2020-10-28 | ForSight Vision4, Inc. | Porous structures for extended release drug delivery devices |
US20170196802A1 (en) | 2016-01-08 | 2017-07-13 | Abon Pharmaceuticals, Llc | Long Acting Injectable Formulations |
EP3439591B1 (en) | 2016-04-05 | 2020-09-23 | ForSight Vision4, Inc. | Implantable ocular drug delivery devices |
SI3266446T1 (sl) * | 2016-07-07 | 2019-02-28 | Laboratorios Salvat, S.A. | Oftalmična sestava, obsegajoča ricinusovo olje in triglicerid s srednjo verigo |
KR20200093581A (ko) | 2017-11-21 | 2020-08-05 | 포사이트 비젼4, 인크. | 확장 가능한 포트 전달 시스템을 위한 유체 교환 기기 및 사용 방법 |
WO2019213326A1 (en) * | 2018-05-01 | 2019-11-07 | Idrop, Inc. | Eye drop formulation and method for sustained delivery of medicament to the retina |
CN109091675B (zh) * | 2018-08-31 | 2021-09-17 | 杭州赫尔斯科技有限公司 | 一种复方低浓度阿托品类药物滴眼液及其制备方法 |
CN113749092A (zh) * | 2020-06-03 | 2021-12-07 | 迈克斯(如东)化工有限公司 | 不饱和脂肪酸酯化物应用、农化组合物和低眼刺农药制剂及其应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3767788A (en) * | 1970-06-08 | 1973-10-23 | Burton Parsons Chemicals Inc | Ophthalmic solution |
BE1003578A4 (fr) * | 1988-10-26 | 1992-04-28 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine. |
JP2613139B2 (ja) * | 1990-07-19 | 1997-05-21 | エスエス製薬 株式会社 | キノロンカルボン酸誘導体 |
US5518731A (en) * | 1990-09-27 | 1996-05-21 | Allergan, Inc. | Nonaqueous fluorinated drug delivery vehicle suspensions |
US5912015A (en) * | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US5384333A (en) * | 1992-03-17 | 1995-01-24 | University Of Miami | Biodegradable injectable drug delivery polymer |
US5366739A (en) * | 1992-08-06 | 1994-11-22 | Deo Corporation | Method of ophthalmic drug delivery |
US5830508A (en) * | 1992-08-06 | 1998-11-03 | Deo Corporation | Composition for treating dry eye |
SG49746A1 (en) * | 1992-08-28 | 1998-06-15 | Pharmos Corp | Submicron emulsions as ocular drug delivery vehicles |
US5336487A (en) * | 1993-03-05 | 1994-08-09 | Refojo Miguel F | Method of treating eye disorders with silicon/fluorosilicone copolymer oil |
US5480914A (en) * | 1994-05-06 | 1996-01-02 | Allergan, Inc. | Nonaqueous thixotropic drug delivery suspensions and methods of their use |
US5718922A (en) * | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
WO1998027962A2 (en) * | 1996-12-20 | 1998-07-02 | Alza Corporation | Injectable depot gel composition and method of preparing the composition |
AU754064B2 (en) * | 1998-05-15 | 2002-11-07 | Wakamoto Pharmaceutical Co., Ltd. | Anti-inflammatory eye drops |
US6699492B2 (en) * | 1999-03-31 | 2004-03-02 | Insite Vision Incorporated | Quinolone carboxylic acid compositions and related methods of treatment |
US20030018044A1 (en) * | 2000-02-18 | 2003-01-23 | Peyman Gholam A. | Treatment of ocular disease |
AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
SI1381382T1 (sl) * | 2000-11-01 | 2009-04-30 | Merck Patent Gmbh | Postopki in sestavki za zdravljenje oäśesnih bolezni |
US7354574B2 (en) * | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7417056B2 (en) * | 2004-11-12 | 2008-08-26 | Schering Ag | 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
WO2006133411A1 (en) * | 2005-06-08 | 2006-12-14 | Targegen, Inc. | Methods and compositions for the treatment of ocular disorders |
PT2051710E (pt) * | 2006-08-07 | 2012-02-08 | Bausch & Lomb | Composições e métodos para tratar, reduzir, melhorar ou aliviar doenças oftálmicas do segmento posterior |
JP2010502635A (ja) * | 2006-08-31 | 2010-01-28 | ボーシュ アンド ローム インコーポレイティド | 緑内障またはその進行を治療または予防するための組成物と方法 |
PT2061444E (pt) * | 2006-09-11 | 2011-07-08 | Bausch & Lomb | Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias |
BRPI0811223A2 (pt) * | 2007-06-11 | 2014-10-29 | Bausch & Lomb | Métodos para modular uma inflamação em um paciente, e para tratar, controlar, reduzir ou melhorar uma infecção ocular ou oftálmica e uma sequela inflamatória da mesma, uso de uma fluoroquinolona, e, composição farmacêutica. |
US20090082337A1 (en) * | 2007-09-21 | 2009-03-26 | Srini Venkastesh | Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
-
2008
- 2008-10-22 CA CA2703000A patent/CA2703000C/en not_active Expired - Fee Related
- 2008-10-22 EP EP08848169A patent/EP2214644B1/en not_active Not-in-force
- 2008-10-22 KR KR1020107009886A patent/KR20100067684A/ko not_active Application Discontinuation
- 2008-10-22 AU AU2008325036A patent/AU2008325036B2/en not_active Ceased
- 2008-10-22 CN CN200880114792A patent/CN101848701A/zh active Pending
- 2008-10-22 SG SG2012081634A patent/SG185955A1/en unknown
- 2008-10-22 WO PCT/US2008/080665 patent/WO2009061607A2/en active Application Filing
- 2008-10-22 US US12/741,266 patent/US20100286121A1/en not_active Abandoned
- 2008-10-22 ES ES08848169T patent/ES2402321T3/es active Active
- 2008-10-22 MX MX2010004366A patent/MX2010004366A/es active IP Right Grant
- 2008-10-22 BR BRPI0819175 patent/BRPI0819175A2/pt not_active IP Right Cessation
- 2008-10-22 JP JP2010532144A patent/JP2011502990A/ja active Pending
-
2010
- 2010-11-15 HK HK10110618.9A patent/HK1144073A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20100067684A (ko) | 2010-06-21 |
WO2009061607A2 (en) | 2009-05-14 |
EP2214644B1 (en) | 2013-03-20 |
JP2011502990A (ja) | 2011-01-27 |
ES2402321T3 (es) | 2013-04-30 |
US20100286121A1 (en) | 2010-11-11 |
EP2214644A2 (en) | 2010-08-11 |
CA2703000A1 (en) | 2009-05-14 |
SG185955A1 (en) | 2012-12-28 |
CN101848701A (zh) | 2010-09-29 |
AU2008325036B2 (en) | 2011-10-20 |
AU2008325036A1 (en) | 2009-05-14 |
BRPI0819175A2 (pt) | 2015-05-05 |
MX2010004366A (es) | 2010-05-05 |
WO2009061607A3 (en) | 2009-07-02 |
CA2703000C (en) | 2013-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1144073A1 (en) | Water-immiscible materials as vehicles for drug delivery | |
EP2132133A4 (en) | ADMINISTRATION OF PARTICULATE MEDICINE | |
ZA201002014B (en) | Drug delivery system | |
IL198911A0 (en) | Drug delivery | |
ZA201101737B (en) | Progestin-containing drug delivery system | |
AU2008291328A8 (en) | Aerosols for sinunasal drug delivery | |
GB2442875B (en) | Regulated drug delivery system | |
IL224505A (en) | Device for administering drugs | |
IL207512A0 (en) | Pharmaceutical composition for poorly soluble drugs | |
IL215608A0 (en) | Drug delivery composition | |
IL207366A0 (en) | Drug delivery system with wireless nonitor | |
IL207569A0 (en) | Compositions and methods for drug delivery | |
IL219001A0 (en) | Drug delivery device | |
EP2339973A4 (en) | ACTIVE RELEASE IMPLANTS | |
IL212767A (en) | Device for administering drugs | |
EP2299989A4 (en) | STABILIZED TRANSDERMAL DRUG DISPENSING SYSTEM | |
EP2035488A4 (en) | MICELLES FOR DRUG DELIVERY | |
EP2010162A4 (en) | COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT | |
IL195764A0 (en) | Compositions and methods for drug delivery | |
EP2323587A4 (en) | ACTIVE RELEASE IMPLANTS | |
GB0725321D0 (en) | Delivery vehicles | |
PT2376147T (pt) | Recipiente para fármaco melhorado | |
IL212357A0 (en) | Sustained drug delivery system | |
ZA201103240B (en) | Sustained release drug delivery system | |
EP2258426A4 (en) | DRUGS CONTAINER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20161022 |